Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Pfizer Completes Anacor Acquisition
The Pros And Cons Of Pfizer Separating GEP
Will The Brexit Quake Shake The Dogs Of The Dow? (Seeking Alpha)
Related LNKD
Are You In The Know About IPOs?
Goldman Sachs Implements Millennial-Friendly Interview Process
Why Microsoft Bought LinkedIn (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Jun 2016JefferiesMaintainsBuy
Jun 2016JefferiesMaintainsBuy
May 2016BerenbergInitiates Coverage onHold

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!